Foltabs Prenatal
Name: Foltabs Prenatal
- If your symptoms or health problems do not get better or if they become worse, call your doctor.
- Do not share your drugs with others and do not take anyone else's drugs.
- Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.
- Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.
- Some drugs may have another patient information leaflet. Check with your pharmacist. If you have any questions about this medicine, please talk with your doctor, nurse, pharmacist, or other health care provider.
- If you think there has been an overdose, call your poison control center or get medical care right away. Be ready to tell or show what was taken, how much, and when it happened.
This information should not be used to decide whether or not to take Foltabs Prenatal (vitamins (multiple/prenatal)) or any other medicine. Only the healthcare provider has the knowledge and training to decide which medicines are right for a specific patient. This information does not endorse any medicine as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about this medicine. It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to Foltabs Prenatal. This information is not specific medical advice and does not replace information you receive from the healthcare provider. You must talk with the healthcare provider for complete information about the risks and benefits of using this medicine.
Review Date: October 4, 2017
Container label
FOLTABS CONTAINER LABEL
Foltabs Prenatal prenatal vitamins and minerals tablets tablet |
Product Information | Product Type | HUMAN PRESCRIPTION DRUG LABEL | Item Code (Source) | NDC:68308-165 | Route of Administration | ORAL | DEA Schedule | | |
Active Ingredient/Active Moiety | Ingredient Name | Basis of Strength | Strength | POTASSIUM IODIDE (POTASSIUM CATION) | POTASSIUM IODIDE | 150 ug | IRON PENTACARBONYL (IRON) | IRON PENTACARBONYL | 14 mg | FERROUS GLUCONATE (IRON) | FERROUS GLUCONATE | 13 mg | DOCUSATE SODIUM (DOCUSATE) | DOCUSATE SODIUM | 50 mg | THIAMINE MONONITRATE (THIAMINE) | THIAMINE MONONITRATE | 3 mg | RIBOFLAVIN (RIBOFLAVIN) | RIBOFLAVIN | 3.4 mg | PYRIDOXINE HYDROCHLORIDE (PYRIDOXINE) | PYRIDOXINE HYDROCHLORIDE | 30 mg | FOLIC ACID (FOLIC ACID) | FOLIC ACID | 1 mg | ZINC OXIDE (ZINC) | ZINC OXIDE | 25 mg | CUPRIC OXIDE (COPPER) | CUPRIC OXIDE | 2 mg | ASCORBIC ACID (ASCORBIC ACID) | ASCORBIC ACID | 120 mg | CALCIUM CITRATE (CALCIUM) | CALCIUM CITRATE | 125 mg | NIACINAMIDE (NIACINAMIDE) | NIACINAMIDE | 20 mg | .ALPHA.-TOCOPHEROL ACETATE, DL- (ALPHA-TOCOPHEROL, DL-) | .ALPHA.-TOCOPHEROL ACETATE, DL- | 30 [iU] | CHOLECALCIFEROL (CHOLECALCIFEROL) | CHOLECALCIFEROL | 400 [iU] | |
Product Characteristics | Color | WHITE (White) | Score | 2 pieces | Shape | OVAL (Modified Oval) | Size | 18mm | Flavor | | Imprint Code | ML;160 | Contains | | |
Packaging | # | Item Code | Package Description | 1 | NDC:68308-165-90 | 90 TABLET (TABLET) in 1 BOTTLE | |
|
Marketing Information | Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date | Unapproved drug other | | 01/01/2009 | | |
Labeler - Midlothian Laboratories (142122824) |
Revised: 11/2009 Midlothian Laboratories